| PRODUCT NDC | 63776-250 | The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| PRODUCT TYPE NAME | HUMAN OTC DRUG | Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing. |
| PROPRIETARY NAME | Intra-cell | The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes. |
| NON PROPRIETARY NAME | ingredients | The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product. |
| DOSAGE FORM NAME | SPRAY | The translation of the dosage form Code submitted by the firm. |
| ROUTE NAME | ORAL | The translation of the route code submitted by the firm, indicating route of administration. |
| START MARKETING DATE | 7/24/2012 | This is the date that the labeler indicates was the start of its marketing of the drug product. |
| MARKETING CATEGORY NAME | UNAPPROVED HOMEOPATHIC | Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| LABELER NAME | VIATREXX BIO INCORPORATED | Name of Company corresponding to the labeler code segment of the Product NDC. |
| SUBSTANCE NAME | .ALPHA.-LIPOIC ACID; .ALPHA.-TOCOPHEROL; ACETYLCARNITINE; ADENOSINE TRIPHOSPHATE; ASCORBIC ACID; CALCIUM GLUCONATE; CITRIC ACID MONOHYDRATE; COLCHICUM AUTUMNALE BULB; CONIUM MACULATUM FLOWERING TOP; CUPRIC SULFATE; CYANOCOBALAMIN; FERRIC CHLORIDE HEXAHYDRATE; FOLIC ACID; FUMARIC ACID; LACTIC ACID; MAGNESIUM PHOSPHATE, TRIBASIC, PENTAHYDRATE; MANGANESE GLUCONATE; MANGANESE PHOSPHATE, DIBASIC; MERCURIUS SOLUBILIS; NIACIN; PANTOTHENIC ACID; PHOSPHORUS; PODOPHYLLUM; POTASSIUM ASPARTATE; PYRIDOXINE; PYRUVALDEHYDE; QUINHYDRONE; RIBOFLAVIN; SACCHAROMYCES CEREVISIAE RNA; SELENOMETHIONINE; SODIUM DIETHYL OXALACETATE; SODIUM PYRUVATE; SUCCINIC ACID; SULFUR; THIAMINE; UBIDECARENONE; ZINC GLUCONATE | An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted. |
| ACTIVE NUMERATOR STRENGTH | 30; 30; 30; 30; 30; 30; 30; 200; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30 | |
| ACTIVE INGRED UNIT | [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL | |
| PHARM CLASSES | Acidifying Activity [MoA], Acidifying Activity [MoA], Analogs/Derivatives [Chemical/Ingredient], Anti-coagulant [EPC], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Calcium Chelating Activity [MoA], Calcium [CS], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Carnitine Analog [EPC], Carnitine [CS], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Coagulation Factor Activity [PE], Decreased Copper Ion Absorption [PE], Depigmenting Activity [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Iron [CS], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Melanin Synthesis Inhibitor [EPC], Melanin Synthesis Inhibitors [MoA], Nicotinic Acid [EPC], Nicotinic Acids [CS], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Paramagnetic Contrast Agent [EPC], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin B 12 [CS], Vitamin B 6 [Chemical/Ingredient], Vitamin B12 [EPC], Vitamin B6 Analog [EPC], Vitamin C [EPC] | |